The 6-minute Pegboard and Ring Test in Patients with Fibromyalgia Syndrome

NCT ID: NCT06696287

Last Updated: 2024-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-27

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in patients with fibromyalgia syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with fibromyalgia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with fibromyalgia syndrome
* Being aged 18-65
* Stable use of medication for at least 3 months or longer
* Volunteering to participate in the study

Exclusion Criteria

* Having a musculoskeletal problem that would prevent being tested
* Having cardiopulmonary and neurological disease
* Malignancy
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kirsehir Ahi Evran Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Merve Firat

Asst. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Basak Kavalci Kol

Role: STUDY_CHAIR

Kirsehir Ahi Evran University

Figen Tuncay

Role: STUDY_CHAIR

Kirsehir Ahi Evran University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kirsehir Ahi Evran University

Kırşehir, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Merve Firat

Role: CONTACT

+90 850 441 02 44

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Merve Firat, Assistant Professor

Role: primary

+90 850 441 02 44

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-13/112

Identifier Type: -

Identifier Source: org_study_id